(BC) Brunswick - Overview
Stock: Engines, Electronics, Boats, Parts
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.84% |
| Yield on Cost 5y | 2.07% |
| Yield CAGR 5y | 7.77% |
| Payout Consistency | 95.7% |
| Payout Ratio | 97.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.9% |
| Relative Tail Risk | -11.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.81 |
| Alpha | 14.47 |
| Character TTM | |
|---|---|
| Beta | 1.490 |
| Beta Downside | 1.523 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.47% |
| CAGR/Max DD | 0.05 |
Description: BC Brunswick January 10, 2026
Brunswick Corporation (NYSE: BC) designs, manufactures and markets a broad portfolio of recreational marine products across four operating segments: Propulsion (outboard, sterndrive and in-board engines under the Mercury family), Engine Parts & Accessories (after-market components and lubricants), Navico Group (marine electronics and sensors under brands such as Simrad, Lowrance and B&G) and Boat (consumer-facing brands like Sea Ray, Bayliner, Boston Whaler and Lund). The company serves boat builders, marine dealers and end-consumers in the U.S., Europe, Asia-Pacific and Canada, leveraging an integrated supply chain that spans OEM sales to aftermarket distribution.
Key recent metrics: FY 2023 revenue reached approximately $6.5 billion, with the Boat segment delivering a 12 % YoY sales increase driven by strong demand for mid-size sport boats; the Propulsion segment posted a 13 % operating margin, reflecting pricing power in the outboard market where Mercury holds roughly 30 % market share. Economic drivers include discretionary-spending trends (consumer confidence and household disposable income) and fuel-price volatility, which influence both new-boat purchases and aftermarket parts demand. The marine-electronics space is expanding as boat owners adopt advanced navigation and connectivity solutions, a trend that benefits the Navico Group’s high-margin product lines.
For a deeper, data-rich view of Brunswick’s valuation dynamics, you may find ValueRay’s analyst dashboard worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: -137.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.81 > 1.0 |
| NWC/Revenue: 24.29% < 20% (prev 28.21%; Δ -3.93% < -1%) |
| CFO/TA 0.11 > 3% & CFO 562.1m > Net Income -137.3m |
| Net Debt (38.6m) to EBITDA (268.5m): 0.14 < 3 |
| Current Ratio: 2.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (65.7m) vs 12m ago -1.35% < -2% |
| Gross Margin: 24.84% > 18% (prev 0.26%; Δ 2458 % > 0.5%) |
| Asset Turnover: 97.60% > 50% (prev 92.24%; Δ 5.36% > 0%) |
| Interest Coverage Ratio: -0.21 > 6 (EBITDA TTM 268.5m / Interest Expense TTM 111.7m) |
Altman Z'' 5.16
| A: 0.25 (Total Current Assets 1.97b - Total Current Liabilities 670.3m) / Total Assets 5.31b |
| B: 0.64 (Retained Earnings 3.37b / Total Assets 5.31b) |
| C: -0.00 (EBIT TTM -24.0m / Avg Total Assets 5.49b) |
| D: 1.44 (Book Value of Equity 5.31b / Total Liabilities 3.69b) |
| Altman-Z'' Score: 5.16 = AAA |
Beneish M -2.61
| DSRI: 1.19 (Receivables 522.8m/429.0m, Revenue 5.36b/5.24b) |
| GMI: 1.04 (GM 24.84% / 25.79%) |
| AQI: 1.58 (AQ_t 0.60 / AQ_t-1 0.38) |
| SGI: 1.02 (Revenue 5.36b / 5.24b) |
| TATA: -0.13 (NI -137.3m - CFO 562.1m) / TA 5.31b) |
| Beneish M-Score: -2.61 (Cap -4..+1) = A |
What is the price of BC shares?
Over the past week, the price has changed by +9.55%, over one month by +5.06%, over three months by +35.22% and over the past year by +36.23%.
Is BC a buy, sell or hold?
- StrongBuy: 5
- Buy: 3
- Hold: 11
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 86.6 | -1.5% |
| Analysts Target Price | 86.6 | -1.5% |
| ValueRay Target Price | 102.7 | 16.9% |
BC Fundamental Data Overview February 01, 2026
P/S = 0.9773
P/B = 3.2254
P/EG = 0.6068
Revenue TTM = 5.36b USD
EBIT TTM = -24.0m USD
EBITDA TTM = 268.5m USD
Long Term Debt = 2.10b USD (from longTermDebt, two quarters ago)
Short Term Debt = 295.4m USD (from shortTermDebt, last quarter)
Debt = 2.10b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 38.6m USD (from netDebt column, last quarter)
Enterprise Value = 7.09b USD (5.24b + Debt 2.10b - CCE 257.6m)
Interest Coverage Ratio = -0.21 (Ebit TTM -24.0m / Interest Expense TTM 111.7m)
EV/FCF = 17.88x (Enterprise Value 7.09b / FCF TTM 396.3m)
FCF Yield = 5.59% (FCF TTM 396.3m / Enterprise Value 7.09b)
FCF Margin = 7.39% (FCF TTM 396.3m / Revenue TTM 5.36b)
Net Margin = -2.56% (Net Income TTM -137.3m / Revenue TTM 5.36b)
Gross Margin = 24.84% ((Revenue TTM 5.36b - Cost of Revenue TTM 4.03b) / Revenue TTM)
Gross Margin QoQ = 23.08% (prev 25.79%)
Tobins Q-Ratio = 1.33 (Enterprise Value 7.09b / Total Assets 5.31b)
Interest Expense / Debt = 1.19% (Interest Expense 25.0m / Debt 2.10b)
Taxrate = 31.62% (8.60m / 27.2m)
NOPAT = -16.4m (EBIT -24.0m * (1 - 31.62%)) [loss with tax shield]
Current Ratio = 2.94 (Total Current Assets 1.97b / Total Current Liabilities 670.3m)
Debt / Equity = 0.40 (Debt 2.10b / totalStockholderEquity, last quarter 5.31b)
Debt / EBITDA = 0.14 (Net Debt 38.6m / EBITDA 268.5m)
Debt / FCF = 0.10 (Net Debt 38.6m / FCF TTM 396.3m)
Total Stockholder Equity = 3.65b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.50% (Net Income -137.3m / Total Assets 5.31b)
RoE = -3.76% (Net Income TTM -137.3m / Total Stockholder Equity 3.65b)
RoCE = -0.42% (EBIT -24.0m / Capital Employed (Equity 3.65b + L.T.Debt 2.10b))
RoIC = -0.40% (negative operating profit) (NOPAT -16.4m / Invested Capital 4.12b)
WACC = 8.38% (E(5.24b)/V(7.34b) * Re(11.41%) + D(2.10b)/V(7.34b) * Rd(1.19%) * (1-Tc(0.32)))
Discount Rate = 11.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.49%
[DCF Debug] Terminal Value 80.05% ; FCFF base≈343.4m ; Y1≈423.6m ; Y5≈721.4m
Fair Price DCF = 173.6 (EV 11.33b - Net Debt 38.6m = Equity 11.29b / Shares 65.0m; r=8.38% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -67.75 | EPS CAGR: -32.48% | SUE: 0.02 | # QB: 0
Revenue Correlation: -80.98 | Revenue CAGR: -6.20% | SUE: 1.21 | # QB: 5
EPS next Quarter (2026-03-31): EPS=0.44 | Chg30d=-0.332 | Revisions Net=+1 | Analysts=12
EPS current Year (2026-12-31): EPS=4.21 | Chg30d=+0.064 | Revisions Net=+0 | Growth EPS=+28.8% | Growth Revenue=+6.5%
EPS next Year (2027-12-31): EPS=5.18 | Chg30d=-0.005 | Revisions Net=+2 | Growth EPS=+22.9% | Growth Revenue=+4.2%